Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B

Journal of Clinical Investigation

Volumn 102, Issue 5, 1998, Pages 968-975

  Boni, Carolina ^a   Bertoletti, Antonio ^a   Penna, Amalia ^a   Cavalli, Albertina ^a   Pilli, Massimo ^a   Urbani, Simona ^a   Scognamiglio, Paola ^a   Boehme, Richard ^b   Panebianco, Ruggero ^b   Fiaccadori, Franco ^a   Ferrari, Carlo ^a,c  

^a UNIVERSITY OF PARMA   (Italy)

^b GLAXOSMITHKLINE   (United States)

^c UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

Antigen load; Chronic hepatitis B; Lamivudine; T cell response; Viral persistence

Indexed keywords

LAMIVUDINE;

ADULT; ARTICLE; CELLULAR IMMUNITY; CELLULAR IMMUNODEFICIENCY; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HEPATITIS B; HUMAN; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; VIREMIA; VIRUS LOAD; VIRUS PATHOGENESIS;

EID: 0032169470     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI3731     Document Type: Article

References (28)

1. Oldstone, M.B.A. 1991. Molecular anatomy of viral persistence. J. Virol. 65:6381-6383.
2. Doherty, P.C., and R. Ahmed. 1997. Immune response to viral infection. In Viral Pathogenesis. N. Nathanson, editor. Lippincott-Raven Publishers, Philadelphia. 143-161.
3. Ferrari, C., A. Penna, A. Bertoletti, A. Valli, A.D. Antoni, T. Giuherti, A. Cavalli, M.-A. Petit, and F. Fiaccadori. 1990. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J. Immunol. 145:3442-3449.
4. Jung, M., U. Spengler, W. Schraut, R. Hoffman, R. Zachoval, J. Eisemhurg, D. Eichenlaub, G. Riethmuller, G. Paumgartner, H.W.L. Ziegler-Heitbrock, et al. 1991. Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B. J. Hepatol. 13:310-317.
5. Penna, A., F.V. Chisari, A. Bertoletti, G. Missale, P. Fowler, T. Giuberti, F. Fiaccadori, and C. Ferrari. 1991. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. J. Exp. Med. 174:1565-1570.
6. Nayersina, R., P. Folwer, S. Guilhot, G. Missale, A. Cerny, H.-J. Schlicht, A. Vitiello, R. Chesnut, J.L. Person, A.G. Redeker, et al. 1993. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J. Immunol. 150:4659-4671.
7. Chisari, F.V., and C. Ferrari. 1995. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13:29-60.
8. Vitiello, A., G. Ishioka, H.M. Grey, R. Rose, P. Farness, R. LaFond, L. Yuan, and R. Chesnut. 1995. Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans. J. Clin. Invest. 95:341-349.
9. Doong, S.L., C.H. Tsai, R.F. Schinazi, D.C. Liotta, and Y.C. Cheng. 1991. Inhibition of the replication of hepatitis B virus in vitro by 2′,3′-dideoxy-3′-thiacytidine and related analogues. Proc. Natl. Acad. Sci. USA. 88:8495-8499.
10. Dienstag, J.L., R.P. Perrillo, E.R. Schiff, M. Bartholomew, C. Vicary, and M. Rubin. 1995. A preliminary trial of lamivudine for chronic hepatitis B infection. N. Engl. J. Med. 333:1657-1661.
11. Lisignoli, G., A. Facchini, L. Cattini, M.C.G. Monaco, A. Degrassi, and E. Mariani. 1992. In vitro toxicity of 2′,3′-dideoxy-3′-thiacytidine (BCH189/3TC), a new synthetic anti-HIV-1 nucleoside. Antiviral Chem. and Chemother. 3:299-303.
12. Lisignoli, G., M.C.G. Monaco, A. Degrassi, S. Toneguzzi, E. Ricchi, P. Costigliola, and A. Facchini. 1993. In vitro immunotoxicity of 2′-deoxy-3′-thiacytidine, a new anti-HIV agent. Clin. Exp. Immunol. 92:455-459.
13. Pasek, M., T. Goto, W. Gilbert, B. Zink, H. Schaller, P. Mackay, G. Leadbetter, and K. Murray. 1979. Hepatitis B virus genes and their expression in E. coli. Nature. 282:575.
14. Milich, D.R., A. McLachlan, S. Stahl, P. Wingfield, G.B. Thornton, J.L. Hughes, and J.E. Jones. 1988. Comparative immunogenicity of hepatitis B virus core and e antigens. J. Immunol. 141:3617-3624.
15. Saxon, A., J. Feldhaus, and R.A. Robins. 1976. Single step separation of human T and B cells using AET-treated sheep red cells. J. Immunol. Methods. 12:285-290.
16. Taswell, C. 1986. Limiting dilution assays for the separation, characterization, and quantitation of biologically active particles and their clonal progeny. In Cell Separation: Selected Methods and Applications. A. Pretlow and P. Pretlow, editors. Academic Press, New York. 120-141.
17. Tsai, S.L., P.J. Chen, M.Y. Lai, P.M. Yang, J.L. Sung, J.H. Huang, L.H. Hwang, T.H. Chang, and D.S. Chen. 1992. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen conversion. J. Clin. Invest. 89:87-96.
18. Maruyama, T., S. Iino, K. Koike, K. Yasuda, and D.R. Milich. 1993. Serology of acute exacerbation in chronic hepatitis B virus infection. Gastroenterology. 105:1141-1151.
19. Petricoin, E.F., S. Ito, B.L. Williams, S. Audet, L.F. Stancato, A. Gamero, K. Clouse, P. Grimley, A. Weiss, J. Beeler, et al. 1997. Antiproliferative action of interferon-a requires components of T-cell-receptor signalling. Nature. 390:629-632.
20. Marinos, G., N.V. Naoumov, and R. Williams. 1996. Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection. Hepatology. 24:991-995.
21. Webb, S., C. Morris, and J. Sprent. 1990. Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell. 63:1249-1256.
22. Moskophidis, D., F. Lechner, H. Pircher, and R.M. Zinkernagel. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature. 362:758-762.
23. Critchfield, J.M., M.K. Rache, J.C. Zùniga-Pflucker, B. Cannella, C.S. Raine, J. Goverman, and M.J. Lenardo. 1994. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science. 263:1139-1143.
24. Ferrari, C., A. Bertoletti, A. Penna, A. Cavalli, A. Valli, G. Missale, M. Pilli, P. Fowler, T. Giuberti, F.V. Chisari, et al. 1991. Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen. J. Clin. Invest. 88:214-222.
25. Alcamì, A., and G.L. Smith. 1995. Cytokine receptors encoded by poxviruses: a lesson in cytokine biology. Immunol. Today. 16:474-178.
26. Hsu, D.H., R. de Waal Malefyt, F. Fiorentino, M.N. Dang, P. Vieira, J. deVries, and H. Spits. 1996. Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science. 250:830-832.
27. Moore, K.W., P. Vieira, D.F. Fiorentino, M.L. Trounstine, T.A. Khan, and T.R. Mosmann. 1990. Homology of cytokine synthesis inhibitory factor (IL10) to the Epstein-Barr virus gene BCRF1. Science. 248:1230-1234.
28. Gooding, L.R. 1992. Virus proteins that counteract host immune defense. Cell. 71:5-7.